Get started
Author

M. Gamaz

Observed names: Gamaz, Malika Makhlouf, M Gamaz, M. B. Gamaz, M. Gamaz Bensaou, Malika Gamaz, Malika Gamaz Bensaou, Malika Makhlouf Gamaz
OpenAlex ID: A5047632809
Incidence of lung cancer in males and females in Algeria: The lung cancer registry in Algeria (LuCaReAl)
2020 · Adda Bounedjar, Radjâa Benkali, et al. · Cancer Epidemiology · 4
Gemcitabine/docetaxel (GD) versus gemcitabine/cisplatin (GC) in stage III/IV non-small cell lung cancer (NSCLC): Preliminary results
2006 · M. Gamaz, T. Makhloufi, et al. · Journal of Clinical Oncology · 4
Precision-medicine management recommendations for advanced non-small cell lung cancer: expert consensus
2025 · Hampig Raphael Kourie, Mounir Ahmed Bachouchi, et al. · Future Oncology · 2
A retrospective analysis to evaluate adjuvant chemotherapy after radical surgery on survival and disease recurrence in patients with stage I, II, IIIA non-small cell lung cancer (NSCLC)
2004 · M. Gamaz, S. Ameur, et al. · Journal of Clinical Oncology · 1
PUB088 ERLOTINIB in Second Line Treatment of Metastatic Lung Cancer: About 20 Case of Non-Small Cell LUNG
2017 · Nahla Teyar, Malika Gamaz Bensaou, et al. · Journal of Thoracic Oncology
94p Prevalence of Activating Egfr Mutations in Patients With Adenocarcinoma of Lung Cancer in Algerian Series
2013 · M. Gamaz Bensaou, N. Mehenni Allalouche, et al. · Lung Cancer
81p Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung Cancer
2013 · M. Gamaz Bensaou, N. Mehenni Allalouche, et al. · Lung Cancer
9068 Analysis of experience with cisplatin or carboplatin in first line combination chemotherapy with paclitaxel for advanced and metastatic Non Small Cell Lung cancer (NSCLC)
2009 · M. Gamaz, K. Bouzid · European Journal of Cancer Supplements
Use of gemcitabine plus vinorelbine (GV) to treat advanced and metastatic non-small cell lung cancer (NSCLC) in second line after recurrent disease
2009 · M. B. Gamaz, K. Bouzid · Journal of Clinical Oncology
Prise en charge multidisciplinaire du cancer bronchique dans un service spécialisé d'Alger 1999-2001
2008 · A Fissah, L Mellah, et al.
6618 POSTER Gemcitabine and docetaxel in non-small cell lung cancer (NSCLC) and study of prognostic factors
2007 · M. Gamaz, K. Bouzid, et al. · European Journal of Cancer Supplements
P3-176: Prognostic factors for patients with advanced and metastatic non small cell lung cancer (NSCLC): classical factors= performans status (PS), gender and extension of disease; new factors= expression of EGFR, p53 and cell proliferation defined by Ki67
2007 · Malika Gamaz, Kamel Bouzid, et al. · Journal of Thoracic Oncology
Works count: 13
Citation count: 11
H-index: 2
I10-index:
Year
Topic
Type